Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Major recalls | Permanent pacemakers after TAVR | Sustainable cath labs | The rise of AI | More from the last week
Saturday, July 29, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA announces recall of nearly 8,000 Impella blood pumps due to risk of injury or death in TAVR patients

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of nearly 8,000 Impella blood pumps due to risk of injury or death in TAVR patients

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
There have been 30 complaints so far about this issue, including 26 injuries and four deaths.
READ MORE >

Abbott recalls delivery sheath for LAA occluder device after 16 injuries

The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

Abbott recalls delivery sheath for LAA occluder device after 16 injuries

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The FDA has categorized this as a Class I recall, which means using the devices “may cause serious injuries or death.”
READ MORE >

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

New U.S. guidelines on chronic coronary disease rethink use of beta-blockers, other medications

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
The updated recommendations from the American College of Cardiology and American Heart Association cover a variety of topics, including patient communication, follow-up imaging, nutritional supplements and more. 
READ MORE >

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Share on Twitter Share on Facebook Share on Linkedin
Researchers explored data from more than 3,000 TAVR patients, presenting their results in JACC: Cardiovascular Interventions. 
READ MORE >

Atrial fibrillation after TAVR linked to much higher risk of death, heart failure

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

READ MORE >
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Share on Twitter Share on Facebook Share on Linkedin

Atrial fibrillation after TAVR linked to much higher risk of death, heart failure

Share on Twitter Share on Facebook Share on Linkedin
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.
Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.
READ MORE >

How cath labs can limit waste and become more sustainable

Making cardiac catheterization labs more efficient and less wasteful could help reduce the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.

READ MORE >
Making cardiac catheterization labs (CCLs) more efficient less wasteful could go a long way toward reducing the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

How cath labs can limit waste and become more sustainable

Share on Twitter Share on Facebook Share on Linkedin
Making cardiac catheterization labs (CCLs) more efficient less wasteful could go a long way toward reducing the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
Making cardiac catheterization labs more efficient and less wasteful could help reduce the large carbon footprint associated with healthcare, according to a new commentary published in JACC: Cardiovascular Interventions.
READ MORE >

New research suggests immunotherapy for AFib could be on the horizon

Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New research suggests immunotherapy for AFib could be on the horizon

Share on Twitter Share on Facebook Share on Linkedin
Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.
READ MORE >

The rise of AI and other key takeaways for sonographers at ASE 2023

Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 

READ MORE >
Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.
Share on Twitter Share on Facebook Share on Linkedin

The rise of AI and other key takeaways for sonographers at ASE 2023

Share on Twitter Share on Facebook Share on Linkedin
Video of Maddie Jankowski explaining sonographer highlights and trends at the American Society of Echo (ASE) 2023 meeting.
Cardiac sonographer Maddie Jankowski, BS, ACS, RDCS, joined us to explore key trends and updates for sonographers from ASE 2023 in National Harbor, Maryland. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup